Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment: A Randomized Controlled Trial

NCT04302402 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT04302402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04302402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment: A Randomized Controlled Trial
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2020
Completion date
March 31, 2023
Enrollment
132 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia